SE523216C2 - Heparinstent - Google Patents

Heparinstent

Info

Publication number
SE523216C2
SE523216C2 SE0102621A SE0102621A SE523216C2 SE 523216 C2 SE523216 C2 SE 523216C2 SE 0102621 A SE0102621 A SE 0102621A SE 0102621 A SE0102621 A SE 0102621A SE 523216 C2 SE523216 C2 SE 523216C2
Authority
SE
Sweden
Prior art keywords
medical device
glucosaminoglucan
carrier material
acid
layer
Prior art date
Application number
SE0102621A
Other languages
English (en)
Swedish (sv)
Other versions
SE0102621D0 (sv
SE0102621L (sv
Inventor
Jan Harnek
Eftichia-Vassiliki Zouka
Original Assignee
Zoucas Kirurgkonsult Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoucas Kirurgkonsult Ab filed Critical Zoucas Kirurgkonsult Ab
Priority to SE0102621A priority Critical patent/SE523216C2/sv
Publication of SE0102621D0 publication Critical patent/SE0102621D0/xx
Priority to EP02746282A priority patent/EP1418887B1/en
Priority to AT02746282T priority patent/ATE308973T1/de
Priority to DE60207265T priority patent/DE60207265T2/de
Priority to PCT/SE2002/001356 priority patent/WO2003011250A1/en
Priority to US10/484,935 priority patent/US20050171600A1/en
Publication of SE0102621L publication Critical patent/SE0102621L/xx
Publication of SE523216C2 publication Critical patent/SE523216C2/sv
Priority to HK04109121A priority patent/HK1066168A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE0102621A 2001-07-27 2001-07-27 Heparinstent SE523216C2 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0102621A SE523216C2 (sv) 2001-07-27 2001-07-27 Heparinstent
EP02746282A EP1418887B1 (en) 2001-07-27 2002-07-08 Heparin stent
AT02746282T ATE308973T1 (de) 2001-07-27 2002-07-08 Heparin-stent
DE60207265T DE60207265T2 (de) 2001-07-27 2002-07-08 Heparin-stent
PCT/SE2002/001356 WO2003011250A1 (en) 2001-07-27 2002-07-08 Heparin stent
US10/484,935 US20050171600A1 (en) 2001-07-27 2002-07-08 Heparin stent
HK04109121A HK1066168A1 (en) 2001-07-27 2004-11-18 Heparin stent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102621A SE523216C2 (sv) 2001-07-27 2001-07-27 Heparinstent

Publications (3)

Publication Number Publication Date
SE0102621D0 SE0102621D0 (sv) 2001-07-27
SE0102621L SE0102621L (sv) 2003-01-28
SE523216C2 true SE523216C2 (sv) 2004-04-06

Family

ID=20284948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102621A SE523216C2 (sv) 2001-07-27 2001-07-27 Heparinstent

Country Status (7)

Country Link
US (1) US20050171600A1 (xx)
EP (1) EP1418887B1 (xx)
AT (1) ATE308973T1 (xx)
DE (1) DE60207265T2 (xx)
HK (1) HK1066168A1 (xx)
SE (1) SE523216C2 (xx)
WO (1) WO2003011250A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US6790228B2 (en) * 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6569194B1 (en) 2000-12-28 2003-05-27 Advanced Cardiovascular Systems, Inc. Thermoelastic and superelastic Ni-Ti-W alloy
US7939094B2 (en) * 2002-06-19 2011-05-10 Boston Scientific Scimed, Inc. Multiphase polymeric drug release region
US8313759B2 (en) * 2003-03-06 2012-11-20 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
WO2004108792A2 (en) * 2003-04-10 2004-12-16 Vinod Chintamani Malshe Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof
US20060015170A1 (en) * 2004-07-16 2006-01-19 Jones Ryan A Contrast coated stent and method of fabrication
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
EP1832289A3 (en) * 2006-03-08 2007-12-12 Sahajanand Medical Technologies PVT. ltd Compositions and coatings for implantable medical devices
US8084077B2 (en) 2007-05-25 2011-12-27 Abbott Laboratories One-step phosphorylcholine-linked polymer coating and drug loading of stent
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20100070013A1 (en) * 2008-09-18 2010-03-18 Medtronic Vascular, Inc. Medical Device With Microsphere Drug Delivery System
CN109970881B (zh) * 2019-03-01 2021-06-11 暨南大学 3d打印可控释一氧化氮纳米支架材料及制备方法与应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639141A (en) * 1968-09-16 1972-02-01 Cordis Corp Heparinization of plastic
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
US5599352A (en) * 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5861168A (en) * 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
JPH09504274A (ja) * 1993-09-17 1997-04-28 ブリガム アンド ウィメンズ ホスピタル 人工表面および血管面の血栓を予防する酸化窒素付加物の利用
US6087479A (en) * 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US6255277B1 (en) * 1993-09-17 2001-07-03 Brigham And Women's Hospital Localized use of nitric oxide-adducts to prevent internal tissue damage
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5879697A (en) * 1997-04-30 1999-03-09 Schneider Usa Inc Drug-releasing coatings for medical devices
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6342591B1 (en) * 1998-09-22 2002-01-29 Biosurface Engineering Technologies, Inc. Amphipathic coating for modulating cellular adhesion composition and methods
US6379691B1 (en) * 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6575888B2 (en) * 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device

Also Published As

Publication number Publication date
EP1418887A1 (en) 2004-05-19
WO2003011250A8 (en) 2004-04-22
EP1418887B1 (en) 2005-11-09
SE0102621D0 (sv) 2001-07-27
HK1066168A1 (en) 2005-03-18
DE60207265D1 (en) 2005-12-15
SE0102621L (sv) 2003-01-28
WO2003011250A1 (en) 2003-02-13
US20050171600A1 (en) 2005-08-04
ATE308973T1 (de) 2005-11-15
DE60207265T2 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
EP1251902B1 (en) Medical device
US7217426B1 (en) Coatings containing polycationic peptides for cardiovascular therapy
JP4198273B2 (ja) ステントコーティング方法
JP5675611B2 (ja) 生分解性エラストマ及び放出可能なタキサン剤をコーティングした埋込み医療器具
JP5523670B2 (ja) ステント様インプラントにコートされたヘパリンを含有するブロックコポリマー
US20090274737A1 (en) Implant comprising a surface of reduced thrombogenicity
US8512736B2 (en) Coatings including natural biodegradable polysaccharides and uses thereof
US6702850B1 (en) Multi-coated drug-eluting stent for antithrombosis and antirestenosis
US9114198B2 (en) Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
JP2017042634A (ja) 被覆
JP2005523045A (ja) 持効性の薬剤送出系を被覆したステント及びその使用方法
JP2008521495A (ja) 生体有益性コーティングとしてのポリ（エステルアミド）誘導体
KR20040005936A (ko) 공동약물을 함유하는 서방 약물 전달 시스템
US20060204537A1 (en) Silicone blends and composites for drug delivery
JP5602432B2 (ja) 経皮的冠動脈インターベンション用の多剤溶出冠動脈ステント
SE523216C2 (sv) Heparinstent
JP2008289853A (ja) 抗血栓共役体を有する医療装置用のコーティング剤
US20060088571A1 (en) Biocompatible and hemocompatible polymer compositions
JP2012506278A (ja) 被覆ｉｉ
Cheung Hemocompatible polymer thin films fabricated by Electrostatic Self-Assembly (ESA)

Legal Events

Date Code Title Description
NUG Patent has lapsed